• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE DRYSEAL FLEX INTRODUCER SHEATH; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE DRYSEAL FLEX INTRODUCER SHEATH; INTRODUCER, CATHETER Back to Search Results
Model Number DSF2233
Device Problem Use of Device Problem (1670)
Patient Problem Vascular Dissection (3160)
Event Date 09/01/2020
Event Type  Injury  
Manufacturer Narrative
A review of the manufacturing record for the device verified the lot met all pre-release specifications.Also was used dsf1633/21391578 udi# (b)(4).The sheaths were discarded at the facility and not available for analysis.According to the gore® dryseal flex introducer sheath instructions for use (ifu), adequate vessel access is required to introduce the sheath into the vasculature.Careful evaluation of vessel size, anatomy, tortuosity, and disease state (including calcification, plaque, and thrombus) is required to ensure successful sheath introduction and subsequent withdrawal.If vessel is not adequate for access, major bleeding, vessel damage, or serious injury to the patient, including death, may result.According to the ifu size guide, a 22fr sheath minimum id is 7.3mm-8.2mm.According to the ifu size guide, a 16fr sheath minimum id is 5.3mm-6.1mm.It was reported that the diameter of the left external iliac artery was 7mm-7.5mm.Do not attempt to advance the introducer sheath or dilator if resistance is felt.Continued advancement or retraction against resistance may result in major bleeding, vessel damage, serious injury to the patient, or damage to the other device.According to the gore® dryseal flex introducer sheath instructions for use (ifu), adverse events that may occur and / or require intervention include, but are not limited to vascular trauma (i.E., dissection, rupture, perforation, tear, etc.).
 
Event Description
On (b)(6) 2020, the patient underwent endovascular treatment of a thoracic aortic aneurysm using a gore® tag® conformable thoracic stent graft with active control system and gore® dryseal flex introducer sheaths.When a 22 fr sheath was inserted from the left femoral artery, there was resistance and the sheath was not able to be advanced.The 22fr sheath was removed and a 16fr sheath was inserted from the left femoral artery.Then, the 22fr sheath was inserted from the right femoral artery.Reportedly, after all stent grafts were implanted, the angiography imaging identified the left external iliac artery dissection.A bare metal stent was implanted in the dissection site.The patient tolerated the procedure.It was reported that the diameter of the left external iliac artery was 7mm-7.5mm.Additionally, the left common iliac artery and the left external iliac artery were tortuous.It was unknown whether the 22fr or 16fr caused dissection because the angiography was not taken before the 16fr sheath insertion.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE DRYSEAL FLEX INTRODUCER SHEATH
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL PHOENIX 1 B/P
32360 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
nataliya baramzina
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key10519043
MDR Text Key206510760
Report Number3007284313-2020-01061
Device Sequence Number1
Product Code DYB
UDI-Device Identifier00733132630073
UDI-Public00733132630073
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K160254
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 09/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/15/2023
Device Model NumberDSF2233
Device Catalogue NumberDSF2233
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/01/2020
Initial Date FDA Received09/10/2020
Date Device Manufactured01/16/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age78 YR
-
-